NCT03574649 2025-02-21QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung CancerImmunityBio, Inc.Phase 2 Withdrawn